Local Business Alert: (Corrected) Human Genome Sciences rejects buyout offer from GlaxoSmithKline

	Thursday, April 19, 2012 7:48:28 AM LOCAL BUSINESS ALERT (Corrected) Human Genome Sciences rejects buyout offer from GlaxoSmithKline Rockville-based Human Genome Sciences has rejected a buyout offer of $13 a share from British drugmaker GlaxoSmithKline, the company said Thursday. In a statement, the biotech company said the offer "does not reflect the value inherent" in the firm but would prompt the company to launch an evaluation of its "strategic alternatives." Correction: The headline on a previous version of this alert gave an incorrect name for the company Human Genome Sciences. Read more at: http://www.washingtonpost.com/blogs/capital-business/post/human-genome-services-receives-buyout-offer-from-glaxosmithkline/2012/04/19/gIQAwThsST_blog.html Or visit PostBusiness.com or Capital Business. SEND TO A FRIEND UNSUBSCRIBE E-MAIL CENTER GET HELP Washington Post Digital E-mail Customer Care 1150 15th Street NW Washington, D.C. 20071  ©2011 The Washington Post Privacy Policy